Androgen receptor regulates cardiac fibrosis in mice with experimental autoimmune myocarditis by increasing microRNA-125b expression

  • Biochem Biophys Res Commun. 2018 Nov 17;506(1):130-136. doi: 10.1016/j.bbrc.2018.09.092.
Ya Wang  1 Wenhan Ma  1 Shuai Lu  1 LianHua Yan  1 Fen Hu  1 ZhaoHui Wang  2 Bo Cheng  3
Affiliations
  • 1. Laboratory of Cardiovascular Immunology, Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • 2. Laboratory of Cardiovascular Immunology, Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: [email protected].
  • 3. Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: [email protected].
Abstract

Cardiac fibrosis is an important cardiac remodeling event in the development of inflammation dilated cardiomyopathy (iDCM). We have previously observed that degradation enhancer of Androgen Receptor (ASC-J9®) could improve cardiac inflammation and fibrosis. Using Primary CFs, we demonstrated that ASC-J9® attenuates the expression of miR-125b, which subsequently inhibits the generation of Collagen. In contrast, overexpressed AR in CFs induced Collagen production, increases mir-125b.We also found that inhibition of miR-125b attenuates fibrosis which induced by the overexpression of AR. Our results indentify the functional role for AR as a regulator of cardiac fibrosis due to myocarditis and further show that AR exerts its effect by increasing microRNA-125b expression. Treatment with degradation enhancer of AR limits cardiac fibrosis in iDCM, thereby providing potentially a therapeutic approach for patients with iDCM.

Keywords
Androgen receptor; Cardiac fibrosis; Experimental autoimmune myocarditis; microRNA-125b.
Products